title: Roles for pituitary adenylate cyclase-activating peptide (PACAP) expression and signaling in the bed nucleus of the stria terminalis (BNST) in mediating the behavioral consequences of chronic stress.
abstract: Anxiety disorders are frequently long-lasting and debilitating for more than 40 million American adults. Although stressor exposure plays an important role in the etiology of some anxiety disorders, the mechanisms by which exposure to stressful stimuli alters central circuits that mediate anxiety-like emotional behavior are still unknown. Substantial evidence has implicated regions of the central extended amygdala, including the bed nucleus of the stria terminalis (BNST) and the central nucleus of the amygdala as critical structures mediating fear- and anxiety-like behavior in both humans and animals. These areas organize coordinated fear- and anxiety-like behavioral responses as well as peripheral stress responding to threats via direct and indirect projections to the paraventricular nucleus of the hypothalamus and brainstem regions (Walker et al. Eur J Pharmacol 463:199-216, 2003, Prog Neuropsychopharmacol Biol Psychiatry 33(8):1291-1308, 2009; Ulrich-Lai and Herman Nat Rev Neurosci 10:397-409, 2009). In particular, the BNST has been argued to mediate these central and peripheral responses when the perceived threat is of long duration (Waddell et al. Behav Neurosci 120:324-336, 2006) and/or when the anxiety-like response is sustained (Walker and Davis Brain Struct Funct 213:29-42, 2008); hence, the BNST may mediate pathological anxiety-like states that result from exposure to chronic stress. Indeed, chronic stress paradigms result in enhanced BNST neuroplasticity that has been associated with pathological anxiety-like states (Vyas et al. Brain Res 965:290-294, 2003; Pego et al. Eur J Neurosci 27:1503-1516, 2008). Here we review evidence that suggests that pituitary adenylate cyclase-activating polypeptide (PACAP) and corticotropin-releasing hormone (CRH) work together to modulate BNST function and increase anxiety-like behavior. Moreover, we have shown that BNST PACAP as well as its cognate PAC1 receptor is substantially upregulated following chronic stress, particularly in the BNST oval nucleus where PACAP-containing neurons closely interact with CRH-containing neurons (Kozicz et al. Brain Res 767:109-119, 1997; Hammack et al. Psychoneuroendocrinology 34:833-843, 2009). We describe how interactions between PACAP and CRH in the BNST may mediate stress-associated behaviors, including anorexia and anxiety-like behavior. These studies have the potential to define specific mechanisms underlying anxiety disorders, and may provide important therapeutic strategies for stress and anxiety management.
authors.affiliation: Department of Psychology, University of Vermont, Dewey Hall 334, Burlington, VT 05405, USA. sayamwong.hammack@uvm.edu
authors.forename: Sayamwong E
authors.initials: SE
authors.lastname: Hammack
authors.forename: Carolyn W
authors.initials: CW
authors.lastname: Roman
authors.forename: Kimberly R
authors.initials: KR
authors.lastname: Lezak
authors.forename: Margaret
authors.initials: M
authors.lastname: Kocho-Shellenberg
authors.forename: Bethany
authors.initials: B
authors.lastname: Grimmig
authors.forename: William A
authors.initials: WA
authors.lastname: Falls
authors.forename: Karen
authors.initials: K
authors.lastname: Braas
authors.forename: Victor
authors.initials: V
authors.lastname: May
mesh_terms: D000818:Animals; D001007:Anxiety / Q000378:metabolism / Q000503:physiopathology; D001522:Behavior, Animal / Q000502:physiology*; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D006801:Humans; D009473:Neuronal Plasticity / Q000502:physiology; D009479:Neuropeptides / Q000378:metabolism; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide / Q000378:metabolism*; D051237:Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I / Q000378:metabolism; D012686:Septal Nuclei / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology*; D013315:Stress, Psychological / Q000378:metabolism* / Q000503:physiopathology*
chemical_list: D009479:Neuropeptides; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D051237:Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I; D003346:Corticotropin-Releasing Hormone
references.citation: Eur J Pharmacol. 2003 Feb 28;463(1-3):199-216
references.pmid: 12600711
references.citation: Brain Res Mol Brain Res. 2000 Dec 8;84(1-2):79-89
references.pmid: 11113534
references.citation: Mol Pharmacol. 1999 Dec;56(6):1280-7
references.pmid: 10570056
references.citation: J Neurosci. 2003 Jan 1;23(1):23-8
references.pmid: 12514197
references.citation: J Neurochem. 2006 Oct;99(2):499-513
references.pmid: 17029602
references.citation: Endocr Rev. 2000 Feb;21(1):55-89
references.pmid: 10696570
references.citation: J Pharmacol Exp Ther. 1994 Sep;270(3):1282-8
references.pmid: 7932180
references.citation: Brain Res Dev Brain Res. 2000 Mar 15;120(1):27-39
references.pmid: 10727727
references.citation: Neural Plast. 2007;2007:79102
references.pmid: 17641738
references.citation: Neurosci Biobehav Rev. 2005 Jan;28(8):837-50
references.pmid: 15642625
references.citation: Adv Exp Med Biol. 2004;551:77-83
references.pmid: 15602947
references.citation: Br J Pharmacol. 2004 Sep;143(1):107-18
references.pmid: 15302684
references.citation: Behav Neurosci. 2006 Apr;120(2):324-36
references.pmid: 16719697
references.citation: J Neurochem. 2007 Feb;100(3):603-16
references.pmid: 17181550
references.citation: J Physiol. 2004 Feb 15;555(Pt 1):15-26
references.pmid: 14608012
references.citation: J Comp Neurol. 2001 Aug 6;436(4):430-55
references.pmid: 11447588
references.citation: Mol Psychiatry. 2007 Nov;12(11):1026-32
references.pmid: 17387318
references.citation: Biochem Biophys Res Commun. 1990 Jul 31;170(2):643-8
references.pmid: 2383262
references.citation: Brain Res. 1998 Nov 9;810(1-2):211-9
references.pmid: 9813333
references.citation: J Comp Neurol. 1989 Feb 22;280(4):603-21
references.pmid: 2468695
references.citation: Crit Rev Neurobiol. 1996;10(3-4):371-94
references.pmid: 8978987
references.citation: Bioorg Med Chem Lett. 2008 Mar 15;18(6):2162-6
references.pmid: 18272364
references.citation: Endocrinology. 1991 Nov;129(5):2787-9
references.pmid: 1935809
references.citation: Recept Channels. 2002;8(3-4):137-53
references.pmid: 12529932
references.citation: Endocrinology. 2002 Oct;143(10):3946-54
references.pmid: 12239106
references.citation: Nat Rev Neurosci. 2009 Jun;10(6):397-409
references.pmid: 19469025
references.citation: J Biol Chem. 1997 Aug 8;272(32):19666-71
references.pmid: 9242621
references.citation: J Comp Neurol. 1996 Aug 05;371(4):567-77
references.pmid: 8841910
references.citation: Neuroscience. 2004;128(1):7-14
references.pmid: 15450349
references.citation: Ann N Y Acad Sci. 1999 Jun 29;877:281-91
references.pmid: 10415655
references.citation: Neuroendocrinology. 1993 Mar;57(3):517-24
references.pmid: 8391664
references.citation: Peptides. 1997;18(10):1539-45
references.pmid: 9437714
references.citation: Neuron. 1992 Apr;8(4):811-9
references.pmid: 1314625
references.citation: Brain Res Mol Brain Res. 2005 Jul 29;138(1):45-57
references.pmid: 15882914
references.citation: J Neuroendocrinol. 1994 Aug;6(4):433-42
references.pmid: 7987374
references.citation: Psychopharmacology (Berl). 2002 Nov;164(3):318-28
references.pmid: 12424556
references.citation: Neuron. 1993 Aug;11(2):333-42
references.pmid: 8394723
references.citation: J Clin Psychiatry. 2009;70 Suppl 2:10-4
references.pmid: 19371501
references.citation: Ann N Y Acad Sci. 2006 Jul;1070:450-6
references.pmid: 16888208
references.citation: Brain Res Mol Brain Res. 2001 Aug 15;92(1-2):78-84
references.pmid: 11483244
references.citation: Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13355-60
references.pmid: 11687615
references.citation: J Clin Invest. 2000 May;105(9):1307-15
references.pmid: 10792006
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1291-308
references.pmid: 19595731
references.citation: Psychoneuroendocrinology. 2009 Jul;34(6):833-43
references.pmid: 19181454
references.citation: Jpn J Physiol. 1998 Oct;48(5):301-31
references.pmid: 9852340
references.citation: Behav Neurosci. 2004 Apr;118(2):443-8
references.pmid: 15113272
references.citation: Neuroscience. 2006;138(1):235-43
references.pmid: 16359808
references.citation: Nature. 1993 Sep 9;365(6442):170-5
references.pmid: 8396727
references.citation: J Comp Neurol. 2002 Nov 25;453(4):389-417
references.pmid: 12389210
references.citation: J Neurosci. 1997 Aug 15;17(16):6434-46
references.pmid: 9236251
references.citation: Psychopharmacology (Berl). 2002 Jan;159(3):304-10
references.pmid: 11862363
references.citation: Biochem Biophys Res Commun. 1990 Jan 15;166(1):81-9
references.pmid: 2302217
references.citation: J Neurosci. 2004 Oct 6;24(40):8786-95
references.pmid: 15470144
references.citation: J Neurosci. 1997 Jan 1;17(1):83-90
references.pmid: 8987738
references.citation: Eur J Pharmacol. 2000 Jul 28;401(1):39-46
references.pmid: 10915835
references.citation: Peptides. 2007 Sep;28(9):1856-70
references.pmid: 17512639
references.citation: J Biol Chem. 2010 Mar 26;285(13):9749-9761
references.pmid: 20093365
references.citation: J Neurosci. 2003 Jan 1;23(1):12-6
references.pmid: 12514195
references.citation: Neuroscience. 2010 Feb 17;165(4):1025-30
references.pmid: 19931358
references.citation: Pharmacol Rev. 2009 Sep;61(3):283-357
references.pmid: 19805477
references.citation: Brain Res. 1987 Mar 31;407(2):327-31
references.pmid: 3567648
references.citation: Endocr Rev. 2000 Dec;21(6):619-70
references.pmid: 11133067
references.citation: Brain Res. 1999 Nov 27;848(1-2):141-52
references.pmid: 10612706
references.citation: Am J Physiol Regul Integr Comp Physiol. 2008 Mar;294(3):R956-65
references.pmid: 18184762
references.citation: J Biol Chem. 1999 Aug 13;274(33):23103-10
references.pmid: 10438479
references.citation: Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2679-83
references.pmid: 8146174
references.citation: J Biol Chem. 2003 Mar 14;278(11):9630-8
references.pmid: 12524444
references.citation: J Chem Neuroanat. 1991 Jul-Aug;4(4):281-98
references.pmid: 1718318
references.citation: Neuroscience. 2008 Apr 22;153(1):232-9
references.pmid: 18343592
references.citation: J Comp Neurol. 1997 Jul 7;383(3):305-25
references.pmid: 9205043
references.citation: J Comp Neurol. 2003 Dec 8;467(2):232-42
references.pmid: 14595770
references.citation: Am J Physiol Regul Integr Comp Physiol. 2004 Nov;287(5):R1194-201
references.pmid: 15217792
references.citation: Endocrinology. 1995 Sep;136(9):4116-24
references.pmid: 7649120
references.citation: BMC Neurosci. 2004 Sep 20;5:36
references.pmid: 15380027
references.citation: J Neurochem. 2009 Jul;110(2):595-602
references.pmid: 19457081
references.citation: Brain Res. 2003 Mar 7;965(1-2):290-4
references.pmid: 12591150
references.citation: Biol Psychiatry. 2005 Nov 15;58(10):796-804
references.pmid: 16043132
references.citation: J Comp Neurol. 2006 Aug 10;497(5):772-807
references.pmid: 16786552
references.citation: Behav Neurosci. 1988 Apr;102(2):233-43
references.pmid: 3365319
references.citation: Biochem Biophys Res Commun. 1993 Jul 15;194(1):133-43
references.pmid: 7687425
references.citation: Brain Res. 1994 Sep 19;657(1-2):141-9
references.pmid: 7820612
references.citation: FEBS Lett. 1993 Nov 8;334(1):3-8
references.pmid: 8224221
references.citation: Neurosci Lett. 1998 May 1;246(3):145-8
references.pmid: 9792613
references.citation: Behav Neurosci. 1986 Dec;100(6):814-24
references.pmid: 3545257
references.citation: Neurosci Lett. 2004 Apr 22;360(1-2):106-8
references.pmid: 15082190
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2003 Dec;27(8):1177-85
references.pmid: 14659473
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2005 Dec;29(8):1201-13
references.pmid: 16271821
references.citation: Brain Res Brain Res Rev. 2001 Dec;38(1-2):192-246
references.pmid: 11750933
references.citation: Mol Endocrinol. 2001 Oct;15(10):1739-47
references.pmid: 11579206
references.citation: J Comp Neurol. 1996 Dec 09;376(2):278-94
references.pmid: 8951643
references.citation: J Endocrinol. 1999 Jan;160(1):1-12
references.pmid: 9854171
references.citation: Psychoneuroendocrinology. 1998 Apr;23(3):219-43
references.pmid: 9695128
references.citation: Eur J Neurosci. 2008 Mar;27(6):1503-16
references.pmid: 18336570
references.citation: Neurosci Lett. 2010 Jan 14;468(3):300-2
references.pmid: 19914336
references.citation: Brain Res Bull. 1991 Aug;27(2):207-12
references.pmid: 1742609
references.citation: Neuroimage. 2007 Oct 1;37(4):1427-36
references.pmid: 17681799
references.citation: Biochem Biophys Res Commun. 1990 Dec 31;173(3):1271-9
references.pmid: 2268329
references.citation: J Physiol. 1995 May 1;484 ( Pt 3):721-36
references.pmid: 7623287
references.citation: Regul Pept. 2005 May 15;128(1):33-41
references.pmid: 15721485
references.citation: Schizophr Bull. 2011 Jul;37(4):811-21
references.pmid: 19959704
references.citation: Brain Res. 1997 Aug 29;767(1):109-19
references.pmid: 9365022
references.citation: J Neurosci. 2002 Aug 1;22(15):6810-8
references.pmid: 12151561
references.citation: Trends Neurosci. 1997 Feb;20(2):78-84
references.pmid: 9023876
references.citation: J Biol Chem. 1996 Sep 6;271(36):22146-51
references.pmid: 8703026
references.citation: J Comp Neurol. 1989 Feb 22;280(4):587-602
references.pmid: 2708568
references.citation: J Biol Chem. 1997 Jan 10;272(2):966-70
references.pmid: 8995389
references.citation: J Comp Neurol. 1999 Oct 11;413(1):113-28
references.pmid: 10464374
references.citation: Brain Struct Funct. 2008 Sep;213(1-2):29-42
references.pmid: 18528706
references.citation: Nat Genet. 1998 Jun;19(2):162-6
references.pmid: 9620773
references.citation: Biol Psychiatry. 2003 Feb 15;53(4):275-83
references.pmid: 12586446